Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer

Citation
H. Yoshida et al., Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer, INT J ONCOL, 13(6), 1998, pp. 1141-1146
Citations number
26
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF ONCOLOGY
ISSN journal
10196439 → ACNP
Volume
13
Issue
6
Year of publication
1998
Pages
1141 - 1146
Database
ISI
SICI code
1019-6439(199812)13:6<1141:HEONGP>2.0.ZU;2-U
Abstract
The nm23 gene was originally identified by differential hybridization of me tastatic murine melanoma cell lines. Some experimental studies demonstrated a significantly low metastatic potential of melanoma cell lines transfecte d with the nm23 gene. In this study, we clarified the relationship between intracellular nm23-immunoreactivity and lymph nodal status of human breast cancer. We analyzed 82 surgically removed breast tumors including 67 invasi ve carcinomas (ductal, lobular and mucinous carcinomas). The nm23 expressio n was diffusely positive in the benign tumors and non-invasive carcinomas. Of the invasive ductal carcinomas, lymph node metastasis was found in 67.7% (21/31) of the focally positive/negative cases and in 18.2% (4/22) of the diffusely positive cases (p<0.001). Immunohistochemically, advanced margins of invasive carcinomas with lymph node metastasis were shown to be negativ e for nm23 expression, while intraductal carcinoma components were positive . This observation suggested that focally positive/ negative nm23 expressio n can be a predictor of lymph node metastasis of invasive ductal breast car cinoma.